Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus

被引:12
|
作者
Hsu, RB
Chu, SH
机构
[1] Natl Taiwan Univ Hosp, Coll Med, Dept Surg, Taipei 100, Taiwan
[2] Far Eastern Mem Hosp, Taipei, Taiwan
来源
关键词
infective endocarditis; Staphylococcus aureus; methicillin resistance;
D O I
10.1097/00000441-200409000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study sought to determine the impact of methicillin resistance on clinical features and outcomes in patients with Staphylococcus aureus (SA) infective endocarditis (IE). Methods: Retrospective chart review. Univariate and forward stepwise logistic regressions were conducted to determine which factors significantly affected death and systemic embolism. Results: From October 1995 to April 2002, 57 patients with a definite diagnosis of IE caused by SA were included: 28 cases of methicillin-sensitive SA infection and 29 methicillin-resistant SA (MRSA) infection. Patients with MRSA infection are more likely to have old age, underlying diseases, history of hospitalization within the last 6 months, nosocomial infection, and antibiotic use within the last 3 months. Patients with MRSA infection had clinical presentation of less systemic embolism and more sepsis and had a higher 3-month mortality rate. Methicillin resistance is an independent positive predictor of death and a negative predictor of systemic embolism. Conclusions: MRSA became a dominant cause of SA IE. Although it caused a lower incidence of systemic embolism, MRSA infection had a higher mortality rate because of sepsis.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [21] Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis
    Ruggero, Michael A.
    Peaper, David R.
    Topal, Jeffrey E.
    INFECTIOUS DISEASES, 2015, 47 (06) : 379 - 384
  • [22] A CASE OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTIVE ENDOCARDITIS PRESENTING AS NEUTROPHILIC MENINGOENCEPHALITIS
    Karapetians, A.
    Spates, C.
    Heidari, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 151 - 151
  • [23] Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
    Lodise, TP
    McKinnon, PS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) : 113 - 122
  • [24] Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
    Lodise, Thomas P., Jr.
    McKinnon, Peggy S.
    Levine, Donald P.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) : 3731 - 3733
  • [25] Impact of methicillin resistance in Staphylococcus aureus.
    Talon, D
    PATHOLOGIE BIOLOGIE, 1999, 47 (08): : 819 - 826
  • [26] Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis
    Remadi, Jean Paul
    Habib, Gilbert
    Nadji, Georges
    Brahim, Amel
    Thuny, Franck
    Casalta, Jean Paul
    Peltier, Marcel
    Tribouilloy, Christophe
    ANNALS OF THORACIC SURGERY, 2007, 83 (04): : 1295 - 1302
  • [27] Early Infective Endocarditis Due to Staphylococcus aureus Following Dental Procedures
    Kasmi, Gentian
    Refatllari, Etleva
    Dumani, Selman
    Refatllari, Ali
    CLINICAL LABORATORY, 2014, 60 (11) : 1933 - 1936
  • [28] Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia
    Salvador, Vincent Bryan D.
    Chapagain, Bikash
    Joshi, Astha
    Brennessel, Debra J.
    TEXAS HEART INSTITUTE JOURNAL, 2017, 44 (01): : 10 - 15
  • [29] Infective endocarditis due to Staphylococcus aureus -: Deleterious effect of anticoagulant therapy
    Tornos, P
    Almirante, B
    Mirabet, S
    Permanyer, G
    Pahissa, A
    Soler-Soler, J
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (05) : 473 - 475
  • [30] A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance
    Chang, FY
    MacDonald, BB
    Peacock, JE
    Musher, DM
    Triplett, P
    Mylotte, JM
    O'Donnell, A
    Wagener, MM
    Yu, VL
    MEDICINE, 2003, 82 (05) : 322 - 332